Attached files

file filename
EX-32 - OncoCyte Corpex32.htm
EX-31 - OncoCyte Corpex31.htm
EX-21 - OncoCyte Corpex21.htm
EX-10.44 - OncoCyte Corpex10-44.htm
EX-4.11 - OncoCyte Corpex4-11.htm
10-K - OncoCyte Corpform10-k.htm

 

EXHIBIT 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in Amendment No. 2 to Registration Statement on Form S-1 (No. 333-213810), Registration Statements on Form S-3 (Nos. 333-220769, 333-231980, 333-240207 and 333-252765) and in Registration Statements on Form S-8 (Nos. 333-219109, 333-208935, 333-227118 and 333-232773) of OncoCyte Corporation of our report dated March 16, 2021 relating to the financial statements of OncoCyte Corporation, which appears in this Annual Report on Form 10-K.

 

/s/ OUM & Co. LLP

 

San Francisco, California

March 19, 2021